A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial)

INTRODUCTION: Malaria due to Plasmodium knowlesi is reported throughout South-East Asia, and is the commonest cause of it in Malaysia. P. knowlesi replicates every 24 h and can cause severe disease and death. Current 2010 WHO Malaria Treatment Guidelines have no recommendations for the optimal treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigg, M J, William, T, Dhanaraj, P, Menon, J, Barber, B E, von Seidlein, L, Rajahram, G, Price, R N, Anstey, N M, Yeo, T W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139630/
https://www.ncbi.nlm.nih.gov/pubmed/25138814
http://dx.doi.org/10.1136/bmjopen-2014-006005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139630/
https://www.ncbi.nlm.nih.gov/pubmed/25138814
http://dx.doi.org/10.1136/bmjopen-2014-006005

Ejemplares similares